PARTIAL DELETION OF MGLUR1 RECEPTORS PROLONGS LIFE SPAN AND AMELIORATES MOTOR SKILLS AND BIOCHEMICAL AND CELLULAR PARAMETERS IN A MOUSE MODEL OF EXPERIMENTAL ALS
Milanese M., Bonifacino T., Giribaldi F., Melone M., Musante I., Conti F., Puliti A., Bonanno G. |
THE MODULATION OF GLUTAMATE RELEASE BY GROUP I METABOTROPIC GLUTAMATE AUTO-RECEPTORS IN ALS
Bonifacino T., Giribaldi F., Milanese M., Rossi P., Pittaluga A., Puliti A., Usai C., Bonanno G. |
CCL5-MEDIATED CONTROL OF GLUTAMATERGIC TRANSMISSION IN EAE MOUSE CENTRAL NERVOUS SYSTEM
Di Prisco S., Merega E., Lanfranco M., Artuso C., Casazza S., Pittaluga A. |
CCL5-GLUTAMATE CROSSTALK IN MOUSE CENTRAL NERVOUS SYSTEM
Merega E., Di Prisco S., Lanfranco M., Botto V., Pittaluga A. |
GET73 MODULATES RAT EXTRACELLULAR HIPPOCAMPAL CA1 GLUTAMATE AND GABA LEVELS THROUGH A POSSIBLE INVOLVEMENT OF LOCAL MGLU5 RECEPTOR.
Beggiato S., Tomasini M., Antonelli T., Loche A., Tanganelli S., Cacciaglia R., Ferraro L. |
INHIBITION BY NEUROPEPTIDE S OF THE RELEASE OF 5-HT AND GLYCINE FROM MOUSE AMYGDALA AND FRONTAL/PREFRONTAL CORTEX NERVE TERMINALS THROUGH ACTIVATION OF THE NEUROPEPTIDE S RECEPTOR
Gardella E., Romei C., Sabolla C., Fedele E., Raiteri L. |
HISTAMINE RECEPTORS ARE EXPRESSED IN THE HUMAN KIDNEY
Veglia E., Grange C., Camussi G., Chazot P., Fantozzi R., Rosa A. |
CA2+ PERMEABLE AMPA RECEPTORS EVOKE GLUTAMATE RELEASE FROM BERGMANN GLIA PROCESSES
Frattaroli D., Maura G., Passalacqua M., Alloisio S., Nobile M., Cervetto C., Marcoli M. |
THE REGULATORY REGION OF THE CHRFAM7A GENE, THE α7 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT DUPLICATE FORM INVOLVED IN THE CHOLINERGIC ANTI-INFLAMMATORY PATHWAY
Fornasari D., Benfante R. |
FUNCTIONAL CROSS-TALK BETWEEN TLR4 AND NOPR IN HUMAN GLIAL CELLS
Baiula M., Bedini A., Baldi J., Caprini M., Spampinato S. |
FARNESOID-X-RECEPTOR (FXR) AGONIST INT-747 REGULATES THE MRNA EXPRESSION OF HEPATIC CATIONIC AMINO ACID TRANSPORTERS CAT-2A AND CAT-2B
Ferrigno A., Rizzo V., Richelmi P., Vairetti M. |
REGULATION OF INTRAOCULAR PRESSURE: STRUCTURAL ANALYSIS OF DOPAMINERGIC AND SEROTONERGIC SYSTEMS
Platania C., Leggio G., Drago F., Salomone S., Bucolo C. |
MATRIX METALLOPROTEINASE 2 AND 7 ARE NEW TARGETS IN LAM AND TSC-RELATED DISORDERS
Orpianesi E., Lesma E., Ancona S., Chiaramonte E., Di Giulio A., Gorio A. |
PHARMACOLOGICAL MODULATION OF BK CHANNEL IMPROVES CELL VIABILITY UNDER HYPERKALEMIA CONDITION
Tricarico D., Mele A., Calzolaro S., Cannone G., Camerino G., Dinardo M., Latorre R., Conte Camerino D. |
NEW TOCAINIDE DERIVATIVES ARE LEAD BLOCKERS OF NAV1.4 CHANNELS FOR HYPEREXITABILITY DISORDERS OF SKELETAL MUSCLE
De Bellis M., De Luca A., Conte Camerino D., Corbo F., Muraglia M., Franchini C. |
TRPV4 IS DOWNREGULATED IN KERATINOCYTES IN NON-MELANOCITIC HUMAN SKIN CANCER
Minocci D., Fusi C., Maio V., Materazzi S., Massi D., Nassini R. |
THE PHARMACOLOGICAL PROFILE OF KIDNEY CLC-K CHANNELS DEPENDS ON THE EXPRESSION SYSTEM: COMPARISON OF CLC-K CHLORIDE CURRENTS IN A MAMMALIAN CELL LINE AND XENOPUS OOCYTES
Imbrici P., Liantonio A., Giannoccaro A., Gradogna A., Zifarelli G., Laghezza A., Fracchiolla G., Carbonara G., Loiodice F., Pusch M., Conte Camerino D. |
A NOVEL LONG CHAIN TOXIN VARIANT FROM ANDROCTONUS AUSTRALIS SCORPION VENOM ACTIVATES CURRENTS CARRIED BY KV7.4 CHANNELS
Miceli F., Landoulsi Z., Palmese A., Amoresano A., Marino G., El Ayeb M., Benkhalifa R., Taglialatela M. |
REGULATION OF NEURONAL GIRK CHANNEL ACTIVITY BY PALMITATE TURNOVER
Chisari M., Jia L., Sobieski C., Mennerick S., Blumer K. |
PRECLINICAL IN VIVO EVALUATION IN A RAT MODEL OF MYOTONIA CONGENITA OF MARKETED AND INVESTIGATIONAL SODIUM CHANNEL BLOCKERS
Desaphy J., Carbonara R., Costanza T., Lentini G., Corbo F., Franchini C., Conte Camerino D. |
INVOLVEMENT OF NAV1.7 VOLTAGE-GATED SODIUM CHANNELS IN THE ANALGESIC IN VIVO ACTIVITY OF SOME NEWLY-SYNTHESIZED SUMATRIPTAN ANALOGUES
Carbonara R., Carocci A., Franchini C., Lentini G., Conte Camerino D., Desaphy J. |
RETIGABINE INDUCES RELAXATIONS OF THE HUMAN BLADDER DETRUSOR
Bientinesi R., Sacco E., Bassi P., Currò D. |
